Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma.
Edwards JM, Andrews MC, Burridge H, Smith R, Owens C, Edinger M, Pilkington K, Desfrancois J, Shackleton M, Senthi S, van Zelm MC. Edwards JM, et al. Among authors: shackleton m. Clin Transl Immunology. 2023 Sep 7;12(9):e1466. doi: 10.1002/cti2.1466. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37692904 Free PMC article.
Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
Ratnayake G, Reinwald S, Shackleton M, Moore M, Voskoboynik M, Ruben J, van Zelm MC, Yu D, Ward R, Smith R, Haydon A, Senthi S. Ratnayake G, et al. Among authors: shackleton m. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):150-156. doi: 10.1016/j.ijrobp.2020.05.022. Epub 2020 May 22. Int J Radiat Oncol Biol Phys. 2020. PMID: 32450331 Clinical Trial.
Feasibility and Acceptability of Fear-Less: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma.
Lynch FA, Katona L, Jefford M, Smith AB, Shaw J, Dhillon HM, Ellen S, Phipps-Nelson J, Lai-Kwon J, Milne D, Russell L, Dax V, Diggens J, Kent H, Button-Sloan A, Elliott J, Shackleton M, Burridge H, Ftanou M. Lynch FA, et al. Among authors: shackleton m. J Clin Med. 2020 Sep 14;9(9):2969. doi: 10.3390/jcm9092969. J Clin Med. 2020. PMID: 32937942 Free PMC article.
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.
Kuser-Abali G, Zhang Y, Szeto P, Zhao P, Masoumi-Moghaddam S, Fedele CG, Leece I, Huang C, Cheung JG, Ameratunga M, Noguchi F, Andrews MC, Wong NC, Schittenhelm RB, Shackleton M. Kuser-Abali G, et al. Among authors: shackleton m. Oncogene. 2023 Apr;42(17):1360-1373. doi: 10.1038/s41388-023-02631-8. Epub 2023 Mar 11. Oncogene. 2023. PMID: 36906655 Free PMC article.
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma.
Wang W, Smith JL, Carlino MS, Burmeister B, Pinkham MB, Fogarty GB, Christie DRH, Estall V, Shackleton M, Clements A, Wolfe R, Thao LTP, Paton EJ, Steel V, Williams NC. Wang W, et al. Among authors: shackleton m. Clin Transl Radiat Oncol. 2021 Aug 14;30:95-99. doi: 10.1016/j.ctro.2021.08.006. eCollection 2021 Sep. Clin Transl Radiat Oncol. 2021. PMID: 34458597 Free PMC article.
An update on adjuvant systemic therapies in melanoma.
Samuel E, Moore M, Voskoboynik M, Shackleton M, Haydon A. Samuel E, et al. Among authors: shackleton m. Melanoma Manag. 2019 Nov 13;6(3):MMT28. doi: 10.2217/mmt-2019-0009. Melanoma Manag. 2019. PMID: 31807279 Free PMC article. Review.
Reduced melanoma referrals during COVID-19 lockdown.
Berry W, Tan K, Haydon A, Shackleton M, Mar VJ. Berry W, et al. Among authors: shackleton m. Aust J Gen Pract. 2021 Jan 22;50. doi: 10.31128/AJGP-COVID-45. Aust J Gen Pract. 2021. PMID: 33543153 Free article.
176 results